Increasing Prevalence of Cardiovascular Diseases to Augment the Natural Biomaterials Market Growth
Biomaterials can be classified into two main groups, such as
natural and synthetic biomaterials. Natural biomaterial can be any material
taken from plants or animals and can be used to augment, replace, or repair
body tissues and organs. Each of these types has given rise to applications in
specialty areas, ranging from neurology to plastic surgery. Natural
biomaterials offer various advantages over synthetic biomaterials. Therefore,
these biomaterials are usually applied in the repair or replacement of damaged
human tissues and organs.
Market Dynamics:
Increasing prevalence of cardiovascular diseases, cancer,
rheumatoid arthritis, osteoarthritis, and sports injuries is expected to propel
the growth of the natural
biomaterials market. For instance, chronic diseases such as cancer and
heart disease are the leading causes of death and disability in the United
States, according to the Centers for Disease Control and Prevention (CDC).
Moreover, according to Johns Hopkins Medicine, in the U.S., more than 3.5
million children ages 14 and younger get hurt annually playing sports or
participating in recreational activities. Almost one-third of all injuries
incurred in childhood are sports-related injuries.
Rising bio-based research, increasing conferences of
biomaterials, high healthcare expenditure, and developed healthcare
infrastructure are some of the factors expected to fuel the growth of the natural
biomaterials market. Furthermore, increasing research and development
activities are also expected to augment the growth of the natural biomaterials market.
For instance, researchers from the Indian Institute of Science are working
towards advances in the fields of biomaterials and nanotechnology that could
lead to big breakthroughs in the fight against dangerous viruses, such as
coronavirus, by making hospital beds or doorknobs that could fight and kill
viruses on their own.
America and the Asia Pacific is expected to witness substantial
growth in the natural biomaterials market due to the increasing demand for
natural biomaterials for wound healing applications and increasing number of
plastic surgeries in these regions. For instance, in 2018, more than 17.7
million surgical and minimally-invasive cosmetic procedures performed in the
United States, according to the American Society of Plastic Surgeons (ASPS).
Competitive Analysis:
Major players operating in the natural biomaterials market
are Medtronic, Inc., Botiss Biomaterials
GmbH, Corbion N.V., Royal DSM, Invibio Ltd., Biomet, Inc., BASF SE, and Mimetis
Biomaterials.
In February 2021, W. L. Gore & Associates announced that
GORE SYNECOR Intraperitoneal Biomaterial is now available in Europe, Middle
East, and South Africa. The device was designed to address unmet needs in
complex hernia repair, providing rapid vascularity3 and permanent strength with
a low profile for single, effective hernia repair.
In January 2021, Essent Biologics announced its launch as a
new venture to meet the growing need for biomaterials and data to the regenerative
medicine research community.
Comments
Post a Comment